These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. HCC chemoembolization: Still a challenge. Manenti A; Roncati L; Simonini E; Farinetti A Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):e14-e16. PubMed ID: 27522541 [No Abstract] [Full Text] [Related]
48. Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma. Hashimoto M; Watanabe O; Hirano Y; Kato K; Watarai J AJR Am J Roentgenol; 1997 Nov; 169(5):1307-10. PubMed ID: 9353447 [TBL] [Abstract][Full Text] [Related]
49. Liver rupture after transcatheter arterial chemoembolization of a giant hepatocellular carcinoma. Pijl ME; Pattynama PM; van Hoek B J Vasc Interv Radiol; 1999; 10(7):895-7. PubMed ID: 10435707 [No Abstract] [Full Text] [Related]
50. Education and Imaging. Hepatobiliary and Pancreatic: Gas-forming liver abscess caused by Salmonella after transcatheter arterial chemoembolization for hepatocellular carcinoma. Hung YL; Wang CC J Gastroenterol Hepatol; 2015 Oct; 30(10):1449. PubMed ID: 26361363 [No Abstract] [Full Text] [Related]
51. [The value of using MRI in accessing the efficacy of transcatheter arterial chemoembolization in hepatocellular carcinoma]. Wang LD; Yu CX; Qin M Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):872-4. PubMed ID: 19032879 [No Abstract] [Full Text] [Related]
52. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC. Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422 [TBL] [Abstract][Full Text] [Related]
53. How does selective internal radiation therapy compare with and/or complement other liver-directed therapies. Bargellini I Future Oncol; 2014 Nov; 10(15 Suppl):105-9. PubMed ID: 25478780 [No Abstract] [Full Text] [Related]
54. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma. Sakamoto N; Monzawa S; Nagano H; Nishizaki H; Arai Y; Sugimura K Cardiovasc Intervent Radiol; 2007; 30(3):508-11. PubMed ID: 17242878 [TBL] [Abstract][Full Text] [Related]
55. Mesenteric venous thrombosis after transcatheter arterial chemoembolization for hepatocellular carcinoma. Karagiannis SS; Papatheodoridis GV; Cholongitas E; Manesis EK Am J Gastroenterol; 2002 Oct; 97(10):2685-6. PubMed ID: 12385469 [No Abstract] [Full Text] [Related]
56. Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects. Cohen SE; Safadi R; Verstandig A; Eid A; Sasson T; Symmer L; Shouval D Dig Dis Sci; 1997 May; 42(5):938-43. PubMed ID: 9149045 [No Abstract] [Full Text] [Related]
57. Bronchobiliary fistula associated with intrahepatic biloma after transcatheter arterial chemoembolization for hepatocellular carcinoma. Akazawa S; Omagari K; Amenomori M; Nishiyama H; Mizuta Y; Kohno S J Hepatol; 2004 Jun; 40(6):1045-6. PubMed ID: 15158355 [No Abstract] [Full Text] [Related]
58. Transfemoral approach using a 3.5-French catheter system for use in transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: technical assessment. Ohuchi Y; Kaminou T; Hashimoto M; Sugiura K; Adachi A; Kawai T; Endou M; Ogawa T Hepatogastroenterology; 2011; 58(107-108):916-21. PubMed ID: 21830416 [TBL] [Abstract][Full Text] [Related]